Skip to content

Liam Engel

Entheogenesis Australis, Australia; The Mescaline Garden, Australia; NICM Health Research Institute, Western Sydney University, NSW, Australia. Electronic address: liam@themescalinegarden.com.

4 papers in the library · 42 citations · publishing 2020-2025

Papers

Tripping over the other: Could psychedelics increase empathy?

Journal of Evolutionary Psychology September 21, 2020 Emily Blatchford, Stephen Bright, Liam Engel 27 citations

Psychedelic-assisted psychotherapy shows promise for treating various psychological conditions, and increased empathic functioning may be one mechanism behind its clinical effects. Neuropsychological and clinical evidence suggests that psychedelics can enhance empathy through actions on the 5-HT system, default mode network, neural connectivity, and ego dissolution. These changes in empathy are likely linked to well-documented increases in the personality trait of openness following psychedelic use. Enhanced empathic function may have clinical benefits by fostering greater social connectedness and promoting prosocial attitudes and behaviors.

Mescaline, Peyote and San Pedro: Is sustainability important for cacti consumers?

Journal of Psychedelic Studies August 19, 2023 Liam Engel, Monica J. Barratt, Jason Ferris et al. 7 citations

Among 284 people who used mescaline in the past year, 20% had consumed wild-harvested Peyote. Those who preferred Peyote most often cited indigenous cultural traditions (57.8%), availability (40.0%), and environmental sustainability (33.3%) as motivations. San Pedro was the most common mescaline source (56.1%), and those who preferred it cited availability (54.7%), potency (45.3%), and indigenous cultural traditions (44.2%). Price and potency were significantly more important for San Pedro preferrers. Fewer than 7% of San Pedro users had consumed it from native habitats. The findings suggest that promoting cultivated San Pedro could reduce unsustainable wild Peyote consumption.

"Wood-lover paralysis": Describing a toxidrome with symptoms of weakness caused by some lignicolous "wood-loving" Psilocybe mushrooms.

Toxicon : official journal of the International Society on Toxinology June 7, 2025 Simon A Beck, Caine Barlow, Liam Engel et al. 4 citations

A survey of 392 people who consumed psilocybin-containing mushrooms found that 42.1% reported experiencing temporary muscle weakness, a condition called wood-lover paralysis (WLP). Onset typically occurred within 4 hours of ingestion, primarily impairing mobility (80.4%), with some reporting difficulty swallowing (26.7%) and breathing (16.6%). Symptoms persisted into the next day for 48.1% of those affected, and 21.5% experienced a fall or accident. WLP occurred across different preparation methods and growth conditions, with no significant associations with age, gender, health status, or allergies. The results suggest WLP is an under-recognized adverse outcome from certain lignicolous Psilocybe species, warranting further research and awareness for harm reduction.

Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports

Journal of Psychedelic Studies July 17, 2024 Liam Engel, Sascha Thal, Stephen Bright et al. 4 citations

Analysis of 660 posts from online psychedelic forums (The Shroomery and DMT Nexus) about trip sitting revealed that psychedelics discussed include 5-MeO-DMT, ayahuasca, changa, LSA, LSD, and psilocybin. For well-researched substances like LSD and psilocybin, the common dosages determined by a Delphi-style expert panel aligned closely with those used in clinical studies. Many posts indicated that psychedelic care was seen as unnecessary or optional, especially for LSD and LSA, while 5-MeO-DMT was strongly associated with a perceived need for care. Greater psychedelic purity and dosage intensity correlated with a perceived need for care. Oral administration, the most common route, showed lower dosage intensity.